5914 Results

People

  1. Ladanyi
    Ladanyi
  2. Solit
    Solit
  3. Levine
    Levine
  4. Berger
    Berger
  5. Schultz
    Schultz
  6. Arcila
    Arcila
  7. Hakimi
    Hakimi
  8. Chandarlapaty
    Chandarlapaty
  9. Zehir
    Zehir
  10. Mellinghoff
    Mellinghoff

Groups

  1. Human Oncology and Pathogenesis Program (5914)
  2. GSK Faculty (5697)
  3. Department of Medicine (4259)
  4. Department of Pathology and Laboratory Medicine (3037)
  5. Tow Center for Developmental Oncology (TCDO) (2613)
  6. Solid Tumor Oncology Division (2600)
  7. Sloan Kettering Institute Postdocs (1984)
  8. Hematologic Malignancies, Division of (1879)
  9. Center for Hematologic Malignancies (1845)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (1744)
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (2984)
  2. Meeting Abstract (2527)
  3. Review (137)
  4. Editorial (106)
  5. Book Section (54)
  6. Research Letter (41)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (15)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. Human Oncology and Pathogenesis Program (5914)
  2. GSK Faculty (5697)
  3. Department of Medicine (4259)
  4. Department of Pathology and Laboratory Medicine (3037)
  5. Tow Center for Developmental Oncology (TCDO) (2613)
  6. Solid Tumor Oncology Division (2600)

More Groups

People
  1. Marc Ladanyi (1327)
  2. David Solit (779)
  3. Ross Levine (774)
  4. Michael Berger (765)
  5. Nikolaus Schultz (486)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (120)
  2. 2024 (359)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (636)
  2. Blood (495)
  3. Cancer Research (412)
  4. Modern Pathology (299)
  5. Clinical Cancer Research (268)
  6. Laboratory Investigation (263)

More Publications

Publishers
  1. American Association for Cancer Research (871)
  2. Nature Publishing Group (758)
  3. American Society of Clinical Oncology (702)
  4. American Society of Hematology (541)
  5. Elsevier Inc. (420)
  6. Nature Research (312)

More Publishers

Results (5914)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mitogen-activated protein kinase (MAPK) pathway mutations impact phenotype and survival in colorectal liver metastases
    Meeting Abstract

    Frankel, T. L.; Vakiani, E.; DeMatteo, R.; Allen, P.; Fong, Y.; Kingham, T.; Jarnagin, W.; Solit, D.; D'Angelica, M.
    Annals of Surgical Oncology (2014)

    Fulltext@MSK | Save
  • Branched evolution and intratumor heterogeneity of urothelial carcinoma of the bladder
    Meeting Abstract

    Cha, E. K.; Sfakianos, J. P.; Al-Ahmadie, H.; Scott, S. N.; Kim, P. H.; Iyer, G.; Bajorin, D. F.; Rosenberg, J. E.; Berger, M. F.; Bochner, B. H.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy
    Journal Article

    Voss, M. H.; Hakimi, A. A.; Pham, C. G.; Brannon, A. R.; Chen, Y. B.; Cunha, L. F.; Akin, O.; Liu, H.; Takeda, S.; Scott, S. N.; more...
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • PI3K pathway activation in high-grade ductal carcinoma in situ-implications for progression to invasive breast carcinoma
    Journal Article

    Sakr, R. A.; Weigelt, B.; Chandarlapaty, S.; Andrade, V. P.; Guerini Rocco, E.; Giri, D.; Ng, C. K. Y.; Cowell, C. F.; Rosen, N.; Reis-Filho, J. S.; more...
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • Endocrine-related adverse events following ipilimumab in patients with advanced melanoma: A comprehensive retrospective review from a single institution
    Journal Article

    Ryder, M.; Callahan, M.; Postow, M. A.; Wolchok, J.; Fagin, J. A.
    Endocrine-Related Cancer (2014)

    Fulltext@MSK | Save
  • Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence
    Journal Article

    Nissan, M. H.; Pratilas, C. A.; Jones, A. M.; Ramirez, R.; Won, H.; Liu, C.; Tiwari, S.; Kong, L.; Hanrahan, A. J.; Yao, Z.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Molecular pathways: Molecular basis for sensitivity and resistance to JAK kinase inhibitors
    Journal Article

    Meyer, S. C.; Levine, R. L.
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • Disruption of CRAF-Mediated MEK activation is required for effective mek inhibition in KRAS mutant tumors
    Journal Article

    Lito, P.; Saborowski, A.; Yue, J.; Solomon, M.; Joseph, E.; Gadal, S.; Saborowski, M.; Kastenhuber, E.; Fellmann, C.; Ohara, K.; more...
    Cancer Cell (2014)

    Fulltext@MSK | Save
  • Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs
    Journal Article

    Kris, M. G.; Johnson, B. E.; Berry, L. D.; Kwiatkowski, D. J.; Iafrate, A. J.; Wistuba, I. I.; Varella-Garcia, M.; Franklin, W. A.; Aronson, S. L.; Su, P. F.; more...
    JAMA - Journal of the American Medical Association (2014)

    Fulltext@MSK | Save
  • Desmoplastic melanoma with sarcomatoid dedifferentiation
    Journal Article

    Kiuru, M.; McDermott, G.; Berger, M.; Halpern, A. C.; Busam, K. J.
    American Journal of Surgical Pathology (2014)

    Fulltext@MSK | Save